Shivalik Rasayan’s Evaluation Revised Amidst Challenging Market Conditions

Dec 01 2025 10:09 AM IST
share
Share Via
Shivalik Rasayan, a microcap player in the Pesticides & Agrochemicals sector, has recently undergone a revision in its market assessment. This shift reflects changes across key evaluation parameters including quality, valuation, financial trends, and technical outlook, providing investors with a refreshed perspective on the company’s current standing.



Understanding the Shift in Evaluation


The recent revision in Shivalik Rasayan’s evaluation metrics stems from a nuanced analysis of its operational and market performance. The company’s quality indicators remain average, reflecting moderate management efficiency and profitability. Its valuation appears attractive relative to peers, suggesting potential value for investors willing to navigate the risks associated with a microcap entity. However, the technical outlook remains bearish, indicating prevailing downward momentum in the stock price. Financial trends have shown a flat trajectory, signalling limited growth or contraction in recent periods.



Quality Metrics and Profitability Insights


Shivalik Rasayan’s return on equity (ROE) stands at 6.12%, a figure that points to modest profitability relative to shareholders’ funds. This level of ROE suggests that the company generates limited earnings from its equity base, which may be a concern for investors seeking robust returns. Over the past five years, net sales have expanded at an annual rate of 12.50%, indicating some growth in top-line revenue. However, operating profit growth has been minimal at 0.55% annually, highlighting challenges in translating sales growth into operating earnings.



Recent Financial Performance and Market Reaction


In the most recent quarter ending September 2025, the company reported a profit after tax (PAT) of ₹3.05 crores, which reflects a decline of 23.9% compared to the previous period. This contraction in profitability may have contributed to the cautious stance reflected in the technical assessment. The stock’s price movement has been subdued, with a one-day change of -0.14% and a one-week change of -0.15%. Over longer horizons, the stock has experienced significant declines: -8.67% over one month, -10.33% over three months, and a steep -30.79% over six months. Year-to-date returns stand at -47.32%, while the one-year return is -29.94%, underscoring persistent underperformance relative to broader market indices.




Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!



  • - Current monthly selection

  • - Single best opportunity

  • - Elite universe pick


Get the Full Details →




Valuation and Market Capitalisation Context


Shivalik Rasayan’s market capitalisation categorises it as a microcap stock, which typically entails higher volatility and risk compared to larger companies. Despite its small size, the stock’s valuation metrics suggest it is attractively priced relative to its sector peers in Pesticides & Agrochemicals. This valuation attractiveness may appeal to investors with a higher risk tolerance seeking potential upside from undervalued stocks. However, the limited presence of domestic mutual funds—holding effectively zero stake—may indicate a cautious approach by institutional investors, possibly due to concerns about liquidity, business fundamentals, or price levels.



Technical Trends and Market Sentiment


The technical outlook for Shivalik Rasayan remains bearish, reflecting a prevailing downtrend in the stock’s price action. This trend is consistent with the company’s recent financial results and broader market sentiment. The stock has consistently underperformed the BSE500 benchmark over the past three years, with annual returns lagging behind the index in each period. Such persistent underperformance highlights challenges in regaining investor confidence and suggests that market participants remain cautious about the company’s near-term prospects.



Implications of the Revised Evaluation


The revision in Shivalik Rasayan’s evaluation metrics offers a more balanced view of the company’s current position. While the valuation appears compelling, the flat financial trend and bearish technical signals caution investors to carefully weigh risks. The average quality metrics underline the need for improved operational efficiency and profitability to support a more favourable market assessment. For investors, understanding these dynamics is crucial in making informed decisions about exposure to this microcap stock within the Pesticides & Agrochemicals sector.




Shivalik Rasayan or something better? Our SwitchER feature analyzes this micro-cap Pesticides & Agrochemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Sectoral and Industry Considerations


Operating within the Pesticides & Agrochemicals sector, Shivalik Rasayan faces industry-specific challenges such as regulatory pressures, commodity price fluctuations, and demand variability linked to agricultural cycles. These factors can influence both operational performance and investor sentiment. The company’s modest growth in net sales over the past five years contrasts with the subdued operating profit growth, suggesting margin pressures or cost challenges. Investors should consider these sectoral dynamics alongside the company’s individual financial and technical profile when evaluating potential investment opportunities.



Conclusion: Navigating the Revised Market Assessment


The recent revision in Shivalik Rasayan’s evaluation reflects a complex interplay of factors including moderate profitability, attractive valuation, flat financial trends, and bearish technical signals. While the company’s microcap status and sector positioning offer potential for value-oriented investors, the persistent underperformance and cautious institutional interest highlight the risks involved. A thorough understanding of these elements is essential for investors seeking to assess the stock’s prospects within the broader Pesticides & Agrochemicals landscape.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News